Stellaromics Adds Stacie Weninger and Steve McPhail to Board of Directors
Stellaromics has appointed Stacie Weninger, PhD, and Steve McPhail to its Board of Directors, announced in a press release. The company said the appointments come as it scales its Pyxa technology and expands within the life sciences sector.
Dr. Weninger brings over two decades of experience in neuroscience and venture capital, while McPhail has more than 30 years of leadership in genomics and diagnostics. Their combined expertise is expected to support Stellaromics in advancing its spatial analysis tools for researchers and drug developers worldwide.
CEO Todd Dickinson welcomed the new board members, noting their backgrounds will help guide the company’s continued growth and technology expansion.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Nov 13 Bracco and Avicenna.AI win FDA clearance for AI that flags brain aneurysms on CT scans Nov 13 Zus Health raises $33 million to build the data layer for healthcare AI Nov 13 Google DeepMind releases AlphaGenome 2 to predict DNA variant effects in specific cell types Nov 13 Taiwan hospital accelerator T+ MedIC names AI ECG and CT screening tools as first winners Nov 13 Sheinbaum meets OpenAI president Greg Brockman on AI in Mexican healthcareLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
Christopher Stubbs Joins Anthropic's Long-Term Benefit Trust
Flagship Pioneering Merges Three Biotech Platforms Into Etcelera
INmune Bio and QCi Apply Quantum Computing to XPro Research
BioStack Raises $9.5 Million for Medical AI Data Network
Stagwell and Palantir Expand Enterprise AI Marketing Partnership
Daily AI Brief: the AI news that matters, in your inbox.